Thrombin receptor: A novel target for antiplatelet drug development

Thrombosis Research

Volumn 87, Issue 1, 1997, Pages 37-50

  Ray, Abhijit ^a   Hegde, L G ^a   Gupta, J B ^a  

^a RANBAXY LABORATORIES LTD   (India)

Author keywords

Drug Development; Platelet antagonist; Thrombin; Thrombin Receptor

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; ARGATROBAN; CELL ADHESION MOLECULE; FIBRINOGEN RECEPTOR ANTAGONIST; HIRUDIN; LIGAND; MK 0852; POLYCLONAL ANTIBODY; RECEPTOR ANTIBODY; RECEPTOR BLOCKING AGENT; THROMBIN; THROMBIN INHIBITOR; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; THROMBOCYTE AGGREGATION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AMINO ACID SEQUENCE; ANIMALS; DRUG DESIGN; HUMANS; MOLECULAR SEQUENCE DATA; PLATELET AGGREGATION INHIBITORS; RECEPTORS, THROMBIN; THROMBIN;

EID: 0030762060     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00102-3     Document Type: Short Survey

References (55)

1. MOMBOULI, J.-V. and VANHOUTTE, P. M. Kinins and endothelial control of vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 35, 679-705, 1995.
2. STRUIJKER-BOUDIER, H. A., SMITS, J. F. M. and DE MEY, JO, G. R. Pharmacology of cardiac and vascular remodelling. Ann. Rev. Pharmacol. Rev. Toxicol. 35, 509-539, 1995
3. TAPPARELLI, C., METTERNICH, R., EHRHARDT, C., and COOK, N. S. Synthetic low molecular weight thrombin inhibitors: molecular design and pharmacological profile.Trends Pharmacol. Sci. 14, 366-376, 1995.
4. FUSTER, V., STEIN, B., AMBROSE, J. A., BADIMON, L., BADIMON, J. J. and CHESEBRO, J. H. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82, receptor 1147-1159, 1990.
5. BAYKAL, D., SCHMEDTJE, J. F. JR., and RUNGE, M. S. Role of the thrombin receptor in restenosis and atherosclerosis Am. J. Cardiol. 75, 82B-87B, 1995.
6. HARKAR, L. A., HANSON, S. R., and RUNGE, M. S. Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol. 75, 12B-17B, 1995.
7. SCARBOROUGH, R. M. Anticoagulant Strategies Targeting Thrombin Receptor and Factor Xa. In: Annual Reports in Medicinal Chemistry-30, , Chapter 8, pp 71-80, Academic Press Inc. 1995.
8. COUGHLIN, S. R., VU, T. K, HUNG, D. T., and WHEATON, V. I. Characterization of a functional thrombin receptor. Issues and opportunities J. Clin. Invest. 89, 351-355, 1992.
9. BRASS. F., AHUJA, M., BEL MONTE, E., PIZARRO, S., TARVER, A., and HOXIE, J., The human platelet thrombin receptor: Turning it on and turning it off. Ann. NY Acad. Sci. 714,1-12. 1994.
10. VU, T-K. H, HUNG, D. T., WHEATON, V. I., and COUGHLIN, S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068, 1991.
11. SIESS, W. Molecular mechanisms of platelet activation. Ann. Rev. Physiol. 69, 60-178, 1989.
12. STEINBERG, S. F., ROBINSON, R. B., LIEBERMAN, H. B., STERN, D. F., and ROSEN, M. R. Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ. Res, 68, 1216-1229, 1991.
13. COOK, N. S., KOTTIRSCH, G., and ZERWES, H-G. Platelet glycoprotein IIb/IIIa antagonists. Drugs of the Future 19, 135-159, 1994.
14. EMORI, T., HIRATA, Y., IMAI, T., OHTA, K., KANNO, K., EGUCHI, S., and MARUMO, F. Cellular mechanism of thrombin on endothelin-1 biosynthesis and release in bovine endothelial cell. Biochem. Pharmacol. 44, 2409-2411, 1992.
15. MARSEN, T. A., SIMONSON, M. S. and DUNN, M. J. Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ. Res. 76, 987-995, 1995.
16. MCEVER, R., P. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J. Cell Biochem. 45, 156-161, 1991.
17. SUGAMA, Y. TIRUPPPATHI, C., OFFAKIDEVI, K., ANDERSON, T. T., FENTON, J., W., and MALIK, A. B. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J. Cell Biol. 119, 935-944, 1992.
18. SLUITER, W., PIETERSMA, A., LAMERS, J. M. and KOSTER, J. F. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanism underlying their expression. J. Cardiovasc. Pharmacol. 22, S37-S44, 1993.
19. GRANDALIANO, G., VALENTE, A.J. and ABBOUD, H.E. A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. J. Exp. Med. 179, 1737-1741, 1994.
20. CRAGO, A., M., WU, H.F., HOFFMAN, M. and CHURCH, F.C. Monocyte chemoattractant activity of Ser195→Ala active site mutant recombinant alpha thrombin. Exp. Cell Res. 219, 650-656, 1995.
21. MCNAMARA, C. A., SAREMBOCK, I. J., GIMPLE, L. W., FENTON, J. W., COUGHLIN, S. R., and OWENS, G.K. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91, 94-98, 1993.
22. BACHHUBER, B. G., SAREMBOCK, I. J., GIMPLE, L. W., MCNAMARA, C. A., and OWENS, G. K. Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure. Am. J. Physiol. 268, C1141-C1147, 1995.
23. OKAZAKI, H., MAJESKY, M. W., HARKER, L. A., and SCHWARTZ, S. M. Regulation of platelet derived growth factor ligand and receptor gene expression by alpha thrombin in vascular smooth muscle cells. Circ. Res. 71, 1285-1293, 1992.
24. VU, T-K. H, WHEATON, V. I., HUNG, D. T., CHARO, I. and COUGHLIN, S. R. Domains specifying thrombin-receptor interaction. Nature 353, 674-677, 1991.
25. ISHII, K., GERSZTEIN, R., ZHENG, Y. W., WELSH, J. B., TURCK, C. W., and COUGHLIN, S. R. Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of P3 aspartate. J. Biol. Chem. 270, 16435-16440, 1995.
26. HARMON, J. T. and JAMIESON, G. A. Activation of platelets by alpha thrombin is a receptor mediated event. J. Biol. Chem. 261, 15928-15933, 1986
27. GLEMBOTSKI, C. C., IRONS, C. E., KROWN, K. A., MURRAY, S. F., SPRENKLE, A. B. and SEI, C. A. Myocardial alpha-thrombin receptor activation induces hypertrophy and increases atrial natriuretic factor gene expression. J. Biol. Chem. 268, 20646-20652, 1993.
28. NELKEN, N.A, SOIFER, S.J, KEEFE, J., VU, T.K, CHARO, I.F, and COUGHLIN, S.R. Thrombin receptor expression in normal and atherosclerotic human arteries. J. Clin. Invest 90, 1614-1621, 1992.
29. HOWELLS G.L., MACEY, M., MURRELL, A. M., GREEN, A. R., CURTIS, M. A., and STONE, S. R. Thrombin receptor expression and function in large granular lymphocyte proliferative disorders. Br. J. Haematol. 88, 383-358, 1988.
30. WEINSTEIN, J. R., GOLD, S. J., CUNNINGHAM, D.D. and GALL, C. M. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15, 2906-2919, 1995.
31. XU., Y., ZACHARIAS, U., PERALDI, M. N., HE, C. J., LU, C., SRAER, J. D., BRASS, L. F., and RONDEAU, E. Constitutive expression and modulation of the functional thrombin receptor in the human kidney. Am. J. Pathol. 146, 101-110, 1995.
32. CHEN, J., BERNSTEIN, H. S., CHEM, M., WANG, L., ISHII, M., TURCK, C. W., and COUGHLIN, S. R. Tethered ligand library for discovery of peptide agonists. J. Biol. Chem. 270, 23398-23401, 1995.
33. BRASS, L. F., VASSALO, R. R., BELMONTE, E., AHUJA, M., CICHOWSKI, K., and HOXIE, J. Structure and function of the human platelet thrombin receptor: Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. J. Biol. Chem. 267, 13795-13798, 1992.
34. COOK J. J., SITKO, G. R., BEDNAR, B., CONDRA, C., MELLOTT, M. J., FENG, D. M., NUTT, R. F., SHAFER, J. A., GOULD, R. J., CONNOLLY, T. M. An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey.Circulation 91, 2961-2971, 1995.
35. TAY-UYBOCO, J., POON, M-C, AHMAD, S. and HOLLENBERG, M. D. Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systems. Br. J. Pharmacol. 115, 569-578, 1995
36. SHANKAR, R., DE LA MOTTE, C. A., POPTIC, E. J., and DICORLETO, P.E. Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocyte cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J. Biol. Chem. 269, 13936-13941, 1994.
37. KRAMER, R. M., ROBERTS, E. F., HYSLOP, P. A., UTTERBACH, B. G., HUI, K. Y. and JAKUBOWSKI, J. A. Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin receptor agonist peptide in human platelets. Evidence for activation of cPLA2 independent of mitogen activated protein kinases ERK1/2. J. Biol. Chem. 270, 14816-23, 1995.
38. CONNOLLY, A. J., ISHIHARA, H., KAHN, M. L., FARESE, R. V. Jr., and COUGHLIN, S. R. Role of the thrombin receptor in development and evidence for a second receptor. Nature, 381, 516-519, 1996.
39. LIU, L., FREEDMAN, J., HORNSTEIN, A., FENTON, J. W., SONG, Y. Q. And OFOSU, F. A. Binding of thrombin to the G-protein linked receptor, and not to glycoprotein Ib, precedes thrombin mediated platelet activation. J. Biol. Chem. 272, 1997-2004, 1997.
40. WILCOX, J.N., RODRIGUEZ, J., SUBRAMANIAN, R., OLLERENSHAW, J., ZHONG, C., HAYWIRE, D.J., HORAIS, C., HANSON, S.R., LUMSDEN, A., and SALAM T. A. Characterization of thrombin receptor expression during vascular lesion formation. Circ. Res. 75, 1029-1038, 1994.
41. CHAIKOF, E. L., CABAN, R., YAN, C. N., RAO, G. N. and RUNGE, M. S. Growth related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences. J. Biol. Chem. 270, 7431-7436, 1995.
42. HOLLENBERG, M. D. Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol. Sci 17, 3-6, 1995.
43. VASSALO, R. R., KIEBER-EMMONS, T., CICHOWSKI, K. and BRASS, L. F. Structure-function relationships in the activation of platelet thrombin receptors by receptor derived peptides. J. Biol. Chem.257, 6081-6085, 1992.
44. CHAO, B. H., KALKUNTE, S., MARAGANORE, J. M., and STONE, S. R. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochem. 31, 6175-6178, 1992.
45. VAN OBBERGHEN-SCHILLING E, RASMUSSEN, U. B., VOURET-CRAVIARI, V., LENTES, K. U., PAVIRANI, A. and POUYSSEGUR, J. Structure activity analysis of synthetic alpha-thrombin-receptor-activating peptides. Biochem. J. 292, 667-671, 1993.
46. LANIYONU A. A. and HOLLENBERG M. D. Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta. Br J Pharmacol 114, 1680-1686, 1995.
47. FENG D.M., VEBER, D.F., CONNOLLY, T.M., CONDRA, C., TANG, M.J., and Nutt, R.F. Development of a potent thrombin receptor ligand. J. Med. Chem. 38, 4125-4130, 1995.
48. ANTONACCIO, M. J., NORMANDIN, D., SERAFINO, R. and MORELAND, S. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle. J. Pharmacol. Exp. Ther. 266, 125-132, 1993.
49. SCARBOROUGH, R. M., TENG, W., NAUGHTON, M. A., ROSE, J. W., ALVES, V., ARFSTEN, A., RAMAKRISHNAN, V. and BLACKHURT, B. (1993) 13th American Peptide Symposium (Abst. No. P632).
50. + exchange by a thrombin receptor antagonist. Biochem. Pharmacol. 49, 519-528, 1995.
51. BERNATOWICZ, M. B., KLIMAS, C. E., HARTL, K. S., PELUSO, M., ALLEGRETO, N. J., and SEILER, S. M. Development of potent thrombin receptor antagonist peptides. J. Med. Chem. 39, 4879-4887, 1996.
52. GULAVITA, N. K., POMPONA, S. A., WRIGHT, A. E., GARAY, M., and SILLS, M. A. Aplysillin A, a thrombin receptor antagonist from the marine sponge Aplysina fistularis fulva. J. Nat. Products 58, 954-957, 1995.
53. ESMON, C. T. The regulation of natural anticoagulant pathway. Science 235, 1348- 1352, 1987.
54. ANTIPLATELET TRIALISTS COLLABORATION Secondary prevention of vascular disease by prolonged antiplatelet treatment. British Med. J. 296, 320-331, 1988.
55. STEERING COMMITTEE OF THE PHYSICIANS' HEALTH STUDY RESEARCH GROUP. Final Report: findings from the aspirin component of the ongoing physicians' health study New Engl. J. Med. 321, 128-135, 1989.